TELSARTAM

This brand name is authorized in Nigeria.

Active ingredients

The drug TELSARTAM contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7015	Tablet	Telsartam 40mg/5mg Tablets TAB 40mg; 5mg	TELSARTAM 40MG/5MG TABLETS B4-7015 TELSARTAM 40MG/5MG TABLETS telmisartan BP 40mg, amlodipine besilate BP eq to amlodipine 5mg. indigo carmine blue. Tablet Prescription Only Medicine (POM) EVANS THERAPEUTICS LIMITED, ABIMBOLA HOUSE, ABIMBOLA WAY, ISOLO INDUSTRIAL ESTATE, ISOLO LAGOS LAGOS Nigeria BHARAT PARENTERALS LTD, SURVEY NO. 144 & 146, JAROD SAMLAYA ROAD, VILL. HARPURA, TAL. SAVIL, DIST. VADODARA - 391520 ( GUJARAT) , INDIA., India 26/01/2023 25/01/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB04	Telmisartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7015